🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchInsulin icodec (Awiqli) — need advice Page 3

Insulin icodec (Awiqli) — need advice

VendorMark Mon, Feb 2, 2026 at 1:53 AM 31 replies 1,494 viewsPage 3 of 7
mike_nyc
VIP Member
5,678
21,345
Nov 2023
New York
Online
Feb 3, 2026 at 12:35 AM#11
Dr.ObesityLA said:
Forest plot interpretation for the the trial evidence meta-analysis: when reading the pooled estimate, pay attention to: Point estimate (HR/RR/OR) —…

No disagreement, though it depends on where somebody is starting from, and this thread has been assuming a starting point nobody stated.

20 18maya_sedona, stefan_berlin, Dr.EM_Chicago and 17 others
Reply Quote Save Share Report
Dr.LeslieOBGYN
Member
567
2,567
May 2024
Dallas, TX
Feb 3, 2026 at 5:18 AM#12
SleepDoc_PDX said:
Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals.

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Adding it to my notes with a link back to this thread.

21 19FranDenver, Dr.BariatricHTX, LindaRN_retired and 18 others
Reply Quote Save Share Report
NauseaFreeNow
Member
345
1,234
Aug 2024
Indiana
Feb 3, 2026 at 10:01 AM#13
Dr.ObesityLA said:
Forest plot interpretation for the the trial evidence meta-analysis: when reading the pooled estimate, pay attention to: Point estimate (HR/RR/OR) —…

Pushing back on Dr.ObesityLA here. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

Last edited: Feb 3, 2026 at 2:01 PM
22 20Dr.PulmRoch, maya_sedona, stefan_berlin and 19 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Feb 3, 2026 at 2:44 PM#14

Adding the numbers, since they settle part of this. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

23 21JessicaM_2024, TomFromTexas, mike.trainer_LA and 20 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Feb 3, 2026 at 7:27 PM#15

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. Carry on.

24 22PurityPaulOR, MaxMetOK, MounjBrad and 21 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register